Feasibility testing of a novel AI-enabled, cloud-based ECG diagnostic solution to enable fast and affordable diagnosis in long-term continuous ambulatory ECG monitoring
Ended Project Grant Awarded Last action
- Award ID
- R41HL160317
- Recipient
-
Zbeats, Inc. UEI FNTAKWMHKQU4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $888,839
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Stony Brook, NY 11790, USA
Award details come from USAspending.gov.
Description
- Abstract
- The proposed observational study is to evaluate the feasibility of a novel ECG monitoring system leveraging concurrent AI and cloud technologies in long-term continuous monitoring (ltcm) in the clinical environment. IT does not intend to use any data or information from the investigational solution to interfere, intervene or affect any clinical decisions made for the participants. Among nearly 2M per year syncope or TIA/stroke patients, 12-15% are cardiac-arrhythmia associated, which usually carries higher risk for long-term disability and even mortality than other-etiologies patients. Proper risk stratification and early initiation of appropriate preventative treatment can result in significant reduction of the cardiac related diseases and their associated mortality. Although ltcm has been proven to be able to detect arrhythmia with high diagnostic yield, the current standard of care has major market pains: 1) days-to-weeks of delay to deliver final report for offline extended holter; 2) low accuracy in stream arrhythmia detection for online mobile cardiac telemetry; and 3) physicians do not have access to patients' ECG data. Zbeats' solution is aiming to improve today's standard of care by addressing technology accessibility and affordability. Zbpro™, zbeats' alpha prototype was validated against our proprietary dataset as well as public datasets required in ansi/aami EC57, demonstrating algorithms, data transmission and visualization work well as expected. In this phase i study, the feasibility will be tested in the clinical environment by completing the following specific aims (SA): SA1: setup data collection systems and provide training to clinical personnel prior to recruitment. SA2: conduct patients' acceptability evaluation by enrolling 60-75 patients to wear the device for up to 7 days. SA3: evaluate the arrhythmia-capturing capability by conducting physician's satisfaction questionnaires after reviewing the reports generated from the study system. SA4: conduct data analysis and start designing the protocol for phase II study. This proposal will undergo collaboration among zbeats, stony brook university hospital and lankenau medical center. The long- term goal is to dramatically improve the current standard of care in ltcm by reducing the time to detection of life-threatening arrhythmia from weeks to minutes for cardiac-related high-risk patients, increase the streaming detection accuracy and reducing the total costs by leveraging AI algorithms, cloud infrastructure and a low-cost flexible-material patch. This cost reduction will lead to more general medical use cases, such as telehealth & remote patient monitoring (RPM) to benefit broader population.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $55,000 | |
| Amendment | $55,000 | |
| Amendment | $259,613 | |
| Amendment | $259,613 | |
| Original award | $259,613 |
Quick answers
Who received award R41HL160317?
R41HL160317 was awarded to Zbeats, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 12, 2022.
How much is award R41HL160317 worth?
$888,839 has been obligated on R41HL160317.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award